Biotecnología
Biotecnología
Nueva IA revela tu verdadera edad biológica con solo cinco gotas de sangre
06/06/2025 -
Un equipo de Osaka ha creado un modelo de IA capaz de estimar la edad biológica con cinco gotas de sangre, midiendo 22 hormonas esteroides y sus interacciones a través de una red...
Un bebé es curado con el primer tratamiento personalizado de edición de genes
16/05/2025 -
El bebé, que ahora tiene 9 meses y medio, se convirtió en el primer paciente de cualquier edad en recibir un tratamiento de edición de genes personalizado, según sus...
Un ADN diseñado por IA logra controlar genes en células de mamífero
13/05/2025 -
El equipo del Centro de Regulación Genómica (CRG) ha llevado a cabo un proyecto de investigación que genera secuencias reguladoras de ADN no presentes en la naturaleza. A...
Frontier Bio’s lab-grown lung tissue – a new way for future transplants and respiratory treatments
02/10/2024 -
Biotechnology research company Frontier Bio has reported progress in developing lab-grown lung tissue, achieved by integrating bioprinting with the natural self-organizing properties of stem cells....
Desarrollan biomaterial que regenera cartílago dañado en las articulaciones
08/08/2024 -
Investigadores de las universidades estadounidenses de Northwestern y Wisconsin-Madison han desarrollado un nuevo material bioactivo que regenera con éxito el cartílago en...
MilliporeSigma Agrees to Acquire Mirus Bio for $600M
27/05/2024 -
Mirus Bio develops & commercializes transfection reagents, which play a critical role in the production of viral vector-based gene therapies.
Nanoscope Therapeutics Names New SVP of Regulatory and Quality
16/05/2024 -
Dr. Khandan Baradaran boasts nearly two decades of experience in manufacturing and regulatory review of gene therapy products.
bluebird bio Completes First Commercial Cell Collection for LYFGENIA
07/05/2024 -
One-time gene therapy for the treatment of sickle cell disease was approved by the FDA in December 2023.
ProPharma & PBL Introduce Cell Factory Box
06/05/2024 -
Enables decentralized manufacturing of all types of Cell & Gene Therapies.
Charles River Launches AAV and LVV Reference Materials Portfolio
06/05/2024 -
Is designed to streamline Cell and Gene Therapy research and development as it scales to Good Manufacturing Practice quality.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
25/04/2024 -
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.
Ferring and SK Pharmteco Partner to Increase Production of ADSTILADRIN
19/04/2024 -
Will scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy.
CSafe Launches Three New Cold Chain Technologies
16/04/2024 -
Multi-Use Dewars designed to serve cell and gene therapy market, CSafe Connect Control Tower monitoring service, and Silverpod MAX RE.
Session at AAPS National Biotechnology Conference to Cover Gene & Therapy Market
16/04/2024 -
‘Cell and Gene Therapies at the Intersection of Business and Science,’ will take place on May 14 at 9:30 a.m. in San Francisco.
Sartorius Partners with TheWell Bioscience for Animal-Free Hydrogels & Bioinks
11/04/2024 -
Aims to enable more customers to get more relevant insights in less time, accelerating time to market.
Ascend Acquires Florida Facility and Expertise, Bolstering Gene Therapy Development
10/04/2024 -
Enters long-term partnership with Beacon to continue manufacturing its products for clinical and commercial use.
Charles River & Axovia Partner to Support Development of Gene Therapies for Ciliopathies
10/04/2024 -
Axovia will leverage Charles River’s plasmid platform and expertise in plasmid DNA production to accelerate time to clinic.
Andelyn Biosciences Partners with Grace Science to Advance GS-100
26/03/2024 -
Will tech transfer Phase I/II/III manufacturing of the suspension process adeno-associated virus (aav) gene therapy for NGLY1 deficiency.
Charles River Extends Gene Therapy Alliance with NUS Medicine
24/03/2024 -
Will support NUS Medicine in the development of engineered stem cells for cancer therapy.
